No Data
No Data
Stifel Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Raises Target Price to $494
Vertex Pharmaceuticals Price Target Raised to $494 From $490 at Stifel
Stifel Adjusts Price Target on Vertex Pharmaceuticals to $494 From $490, Maintains Hold Rating
Weekly Buzz: Tech stocks hit high scores on ominous day
Market Mixed on Friday the 13th | Livestock
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Bullish Law : Nvidia Sales Report will provide the boost next week!
104247826 :
Malik ritduan : ok
105709903财 : good
fatinmr : good
View more comments...